181 related articles for article (PubMed ID: 25970720)
1. Celiac disease-like enteropathy due to antihypertensive therapy with the angiotensin-II receptor type 1 inhibitor eprosartan.
Maier H; Hehemann K; Vieth M
Cesk Patol; 2015; 51(2):87-8. PubMed ID: 25970720
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin blockade with eprosartan: vascular and functional implications.
Ram CV
Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S5-11. PubMed ID: 18093408
[TBL] [Abstract][Full Text] [Related]
3. Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.
Voors AA; van de Wal RM; Hartog JW; Vijn RG; Hummel YM; Plokker TW; van Veldhuisen DJ; Jaarsma W
Cardiovasc Drugs Ther; 2010 Feb; 24(1):33-40. PubMed ID: 20229056
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effects and safety of eprosartan: a meta-analysis of randomized controlled trials.
Xu FY; Yang B; Shi D; Li H; Zou Z; Shi XY
Eur J Clin Pharmacol; 2012 Feb; 68(2):195-205. PubMed ID: 21881888
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.
Dowlatshahi D; Hill MD
Expert Rev Cardiovasc Ther; 2009 May; 7(5):459-64. PubMed ID: 19419253
[TBL] [Abstract][Full Text] [Related]
6. Eprosartan dual action offers clinical benefit for elderly and overweight hypertensives.
Cardiovasc J S Afr; 2004; 15(2):91-2. PubMed ID: 15148545
[No Abstract] [Full Text] [Related]
7. Introduction: The pharmacological profile of eprosartan--implications for cerebrovascular and cardiovascular risk reduction.
de la Sierra A; Ram CV
Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S1-3. PubMed ID: 18093407
[TBL] [Abstract][Full Text] [Related]
8. Costs of eprosartan versus diuretics for treatment of hypertension in a geriatric population: an observational, open-label, multicentre study.
Gregori JA; Nuñez JF; Domínguez-Gil A;
Drugs Aging; 2009; 26(7):617-26. PubMed ID: 19655828
[TBL] [Abstract][Full Text] [Related]
9. Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.
Shlyakhto E
Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S13-8. PubMed ID: 18093409
[TBL] [Abstract][Full Text] [Related]
10. Eprosartan: a review of its use in the management of hypertension.
Robins GW; Scott LJ
Drugs; 2005; 65(16):2355-77. PubMed ID: 16266204
[TBL] [Abstract][Full Text] [Related]
11. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
12. Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study.
Radaideh GA; Choueiry P; Ismail A; Eid E; Berrou JP; Sedefdjian A; Sévenier F; Pathak A
Vasc Health Risk Manag; 2011; 7():491-5. PubMed ID: 21915165
[TBL] [Abstract][Full Text] [Related]
13. Eprosartan.
McClellan KJ; Balfour JA
Drugs; 1998 May; 55(5):713-8; discussion 719-20. PubMed ID: 9585867
[TBL] [Abstract][Full Text] [Related]
14. Eprosartan: a review of its use in hypertension.
Plosker GL
Drugs; 2009; 69(17):2477-99. PubMed ID: 19911859
[TBL] [Abstract][Full Text] [Related]
15. [In diarrhea of unknown origin also think of olmesartan!].
Storr M
MMW Fortschr Med; 2015 Mar; 157(4):34. PubMed ID: 25743974
[No Abstract] [Full Text] [Related]
16. Safety and tolerability of eprosartan.
Gavras I; Gavras H
Pharmacotherapy; 1999 Apr; 19(4 Pt 2):102S-107S. PubMed ID: 10213529
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile of eprosartan: a different angiotensin II receptor blocker.
Blankestijn PJ; Rupp H
Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):253-7. PubMed ID: 18855637
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of eprosartan, a new angiotensin II receptor blocker.
Shusterman NH
Am Heart J; 1999 Sep; 138(3 Pt 2):238-45. PubMed ID: 10467219
[TBL] [Abstract][Full Text] [Related]
19. Sprue-like enteropathy linked to olmesartan.
Campos Ruiz A; Urtasun Arlegui L; Marra-López Valenciano C
Rev Esp Enferm Dig; 2016 May; 108(5):292-3. PubMed ID: 26925975
[TBL] [Abstract][Full Text] [Related]
20. [Adjustment of antihypertensive therapy to a generic eprosartan preparation. Results of a non-interventional study].
Nüdling S; Kahner-Gröne S; Köneke D; Marggraf K; Palissa H
MMW Fortschr Med; 2010 Oct; 152 Suppl 3():96-101. PubMed ID: 21595153
[No Abstract] [Full Text] [Related]
[Next] [New Search]